2025-03-12 13:13:56
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Suven Life Sciences Ltd consolidated Q2FY23 loss at Rs. 23.18 crores
Posted On : 2022-11-12 22:38:41( TIMEZONE : IST )
Suven Life Sciences Limited has reported Consolidated financial results for the period ended September 30, 2022.
Financial Results (Q2 FY2023) - QoQ Comparison
The company has reported total income of Rs. 4.5926 crores during the period ended September 30, 2022 as compared to Rs. 3.9750 crores during the period ended June 30, 2022.
The company has posted net profit / (loss) of Rs. -23.1815 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs. -16.3262 crores for the period ended June 30, 2022.
The company has reported EPS of Rs. -1.59 for the period ended September 30, 2022 as compared to Rs. -1.12 for the period ended June 30, 2022.
| Financials | Q2 FY2023 | Q1 FY2023 | % Change |
| Total Income | ₹ 4.5926 crs | ₹3.9750 crs |  15.54% |
| Net Profit | ₹-23.1815 crs | ₹-16.3262 crs |  41.99% |
| EPS | ₹-1.59 | ₹-1.12 | 41.96% |
Financial Results (Q2 FY2023) - YoY Comparison
The company has reported total income of Rs. 4.5926 crores during the period ended September 30, 2022 as compared to Rs.1.6869 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.-23.1815 crores for the period ended September 30, 2022 as against net profit / (loss) of Rs.-28.2982 crores for the period ended September 30, 2021.
The company has reported EPS of Rs.-1.59 for the period ended September 30, 2022 as compared to Rs.-2.22 for the period ended September 30, 2021.
| Financials | Q2 FY2023 | Q2 FY2022 | % Change |
| Total Income | ₹ 4.5926 crs | ₹1.6869 crs | 172.25% |
| Net Profit | ₹-23.1815 crs | ₹-28.2982 crs |  18.08% |
| EPS | ₹-1.59 | ₹-2.22 | 28.38% |
Financial Results (Half Year Ended FY2023) - YoY Comparison
The company has reported total income of Rs.8.5676 crores during the 6 Months period ended September 30, 2022 as compared to Rs.4.5325 crores during the 6 Months period ended September 30, 2021.
The company has posted net profit / (loss) of Rs.-39.5077 crores for the 6 Months period ended September 30, 2022 as against net profit / (loss) of Rs.-67.5067 crores for the 6 Months period ended September 30, 2021.
The company has reported EPS of Rs.-2.72 for the 6 Months period ended September 30, 2022 as compared to Rs.-5.30 for the 6 Months period ended September 30, 2021.
| Financials | Half Year Ended FY2023 | Half Year Ended FY2022 | % Change |
| Total Income | ₹8.5676 crs | ₹4.5325 crs | 89.03% |
| Net Profit | ₹-39.5077 crs | ₹-67.5067 crs | 41.48% |
| EPS | ₹-2.72 | ₹-5.30 | 48.68% |
Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 61.35 as compared to the previous close of Rs. 60.85. The total number of shares traded during the day was 14781 in over 246 trades.
The stock hit an intraday high of Rs. 62.45 and intraday low of 61.00. The net turnover during the day was Rs. 907066.00.
